e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Higher serum 25(OH)D concentrations are associated with improved FEV1 and FVC in adolescence
Claudia Flexeder, Elisabeth Thiering, Sibylle Koletzko, Dietrich Berdel, Irina Lehmann, Andrea von Berg, BarbaraHoffmann, Carl-Peter Bauer, Joachim Heinrich, Holger Schulz
Source:
Eur Respir J , 49 (4) 1601804; DOI: 10.1183/13993003.01804-2016
Journal Issue:
April
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Claudia Flexeder, Elisabeth Thiering, Sibylle Koletzko, Dietrich Berdel, Irina Lehmann, Andrea von Berg, BarbaraHoffmann, Carl-Peter Bauer, Joachim Heinrich, Holger Schulz. Higher serum 25(OH)D concentrations are associated with improved FEV1 and FVC in adolescence. Eur Respir J , 49 (4) 1601804; DOI: 10.1183/13993003.01804-2016
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Verification of flow rate stability in high-flow nasal cannula devices
DLCO biological controls in clinical practice.
Related content which might interest you:
Raised FeNO is associated with lower FEV1 and FEV1/FVC in children with asthma
Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics
Year: 2019
FVC decline over 1 year predicts mortality but not subsequent FVC decline in patients with IPF
Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside
Year: 2017
Midflows do not vary independently of FEV1 and FVC
Source: Annual Congress 2010 - Quality measurement and improvement in lung function
Year: 2010
Re-assessing the importance of FEV
1
decline
Source: Eur Respir Monogr 2015; 69: 134-142
Year: 2015
Low FEV1/FVC but normal FEV1 in childhood – risk factor or normal variant?
Source: International Congress 2019 – Innovative ways to diagnose and monitor children with lung diseases and sleep-disordered breathing
Year: 2019
Associations of different serum 25(OH)D levels to parameters of respiratory health in COPD patients
Source: Annual Congress 2011 - Respiratory epidemiology: genetics and modifiable risk factors
Year: 2011
Osteoprotogerin plasma concentrations is correlate with forced expiratory volume at 1 second (FEV1) in patients with COPD
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
LATE-BREAKING ABSTRACT: Serum 25(OH)D concentrations are associated with lung function in adolescence
Source: International Congress 2015 – Epidemiology of respiratory disease
Year: 2015
Within session variability of FEV1 and FVC pre- and post-bronchodilation
Source: International Congress 2019 – Quality, performance and interpretation of lung function testing
Year: 2019
Serum vitamin D3 level correlates with FEV1 in patients with advanced COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Maximally attained level of FEV
1
and FEV
1
decline determine airway hyperresponsiveness in adults
Source: Eur Respir J 2003; 22: Suppl. 45, 17s
Year: 2003
Intermediate and severe α
1
-antitrypsin deficiency: influence on plasma α
1
-antitrypsin, FEV
1
and risk of COPD. Three meta-anlyses
Source: Eur Respir J 2002; 20: Suppl. 38, 513s
Year: 2002
Has the determination of the rate of decline of FEV1 added value in addition to the determination of FEV1/FVC and FEV1
Source: International Congress 2016 – Man versus machine: waves, frequency, and more in lung function
Year: 2016
The relationship between the serum YKL-40 level and severity of asthma
Source: Annual Congress 2012 - Asthma management
Year: 2012
Correlation between serum levels of C-reactive protein and peak expiratory flow in persistent asthma: A longitudinal study
Source: Annual Congress 2010 - Occupational and environmental exposures and respiratory disease
Year: 2010
Determinants of serum leptin and adiponectin levels in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 59s
Year: 2005
HDL serum levels are significantly lower in patients with COPD than in never-smokers
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
The association of wheeze and FEV
1
with free androgen index
Source: Annual Congress 2008 - Epidemiology of asthma and allergy
Year: 2008
Association between weight loss and decline in FVC in patients with IPF
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
FEV6 and FEV1/FEV6 have higher association with small airway function and oxygen saturation than FVC and FEV1/FVC in patients with asthma.
Source: Virtual Congress 2020 – Lung function tests and exhaled biomarkers
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept